Melbourne, Oct 23, 2008 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PNK:BTAHY) today announced that it had received written notification from GlaxoSmithKline (GSK) that Relenza sales were $27.1 million and indicative royalties were $1.9 million, for the three months ended 30 September 2008.
